Clinuvel Pharmaceuticals reported 2.43M in Interest Expense on Debt for its fiscal semester ending in June of 2024.


Interest Expense On Debt Change Date
Avita Medical AUD 1.35M 230K Jun/2024
Medical Developments International AUD 21K 23K Jun/2024
Mesoblast 10.46M 260K Jun/2024
Neuren Pharmaceuticals 0 0 Jun/2024
Paradigm Biopharmaceuticals AUD 4K 2.48K Jun/2024
PYC Therapeutics AUD 6K 30.66K Jun/2024
Telix Pharmaceuticals AUD 3.39M 2.92M Dec/2024